Vertex Pharmaceuticals Incorporated - Current Ratio

The Current Ratio as of August 2026 (TTM) for Vertex Pharmaceuticals Incorporated (VX1.DE) is 3.19

According to Vertex Pharmaceuticals Incorporated’s latest financial reports and current stock price. The company's current Current Ratio is 3.19. This represents a change of 11.08% compared to the average of 2.87 of the last 4 quarters.

Vertex Pharmaceuticals Incorporated (VX1.DE) Historical Current Ratio (quarterly & annually)

How has VX1.DE Current Ratio performed in the past?

The mean historical Current Ratio of Vertex Pharmaceuticals Incorporated over the last ten years is 3.58. The current 3.19 Current Ratio has changed 8.79% with respect to the historical average. Over the past ten years (40 quarters), VX1.DE's Current Ratio was at its highest in in the December 2022 quarter at 4.83. The Current Ratio was at its lowest in in the September 2016 quarter at 2.08.

Vertex Pharmaceuticals Incorporated (VX1.DE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Vertex Pharmaceuticals Incorporated Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vertex Pharmaceuticals Incorporated (VX1.DE) Average Current Ratio

How has VX1.DE Current Ratio performed in the past?

The current Current Ratio of Vertex Pharmaceuticals Incorporated (VX1.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vertex Pharmaceuticals Incorporated (VX1.DE) Current Ratio vs. Peers

How is VX1.DE’s Current Ratio compared to its peers?

Vertex Pharmaceuticals Incorporated’s Current Ratio is greater than Medtronic Plc (2.13), greater than Sanofi (0.99), greater than Bristol-Myers Squibb Company (1.53), greater than CVS Health Corporation (0.87), greater than Alnylam Pharmaceuticals, Inc. (3.05), greater than Pfizer Inc. (1.27), greater than Pfizer Inc. (1.27), greater than Gilead Sciences, Inc. (1.27), greater than Stryker Corporation (2.16), greater than Zoetis Inc. (3.08),

Build a custom stock screener for Vertex Pharmaceuticals Incorporated (VX1.DE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vertex Pharmaceuticals Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vertex Pharmaceuticals Incorporated (VX1.DE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vertex Pharmaceuticals Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.